Vascular closure devices
| Vascular closure devices |
| Cardiology Network |
 Discuss Vascular closure devices further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor in Chief: Michael S. Fenster, MD [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Background
At the very heart of any successful endovascular procedure is successful arterial entry and exit. The first successful cardiac catheterization, according to Andre Cournand, was performed on an equine patient in 1844 utilizing a retrograde approach through both the jugular vein and carotid artery1. Human retrograde left heart catheterization was first reported by Zimmerman2 and Limon-Lason3. in 1950. Shortly thereafter in 1953, Seldinger developed the percutaneous technique and this technique was quickly adapted to left heart cardiac catheterizations. With the growth of Interventional Cardiology in the years following Grüntzig’s introduction of coronary angioplasty in 19774 , the percutaneous approach became, and today remains, by far the most common method of performing catheterization, angiography and endovascular intervention. Within the realm of percutaneous approaches, the majority of the procedures are performed from the femoral approach, with a minority being done from a radial approach. Brachial and axillary are also used in a minority of procedures5.
Current Limitations of Vascular Closure Devices
- Compatible primarily with 5–6 Fr sheath technology
- Not proven in ≥7Fr technology
- Require long learning curve
- Small vessel size (<4.0–5.0mm); a contraindication to use
- Non-common femoral artery ‘sticks’; a contraindication to use
- Peripheral vascular disease; a contraindication to use (very common problem)
- Significant endoluminal device components (prone to thrombosis)
- High costs
- Require bed rest post closure
- Impaired or delayed common femoral artery re-entry (re-access concerns)
- Non-inert, very reactive, permanent and absorbable device components (therefore may be prone to infection and common femoral artery scarring)
- Catastrophic complications (1–2%, but may be underreported)
- Poorly compatible with anticoagulated patients (increased bleeding)
References
1. Cournand, A. (1975). Cardiac Catheterization. Development of the technique and its contribution to experimental medicine, and its initial application in man. Acta Med Scand Suppl , 579:1-32.
2. Zimmerman, H., & Scott, R. B. (1950). Catheterization of the left side of the heart in man. Circulation , 1:357.
3. Limon-Lason, R., & Bouchard, A. (1950). El Caterismo Intracardico; Cateterizacion de la Cavidades Izquierdas en el Hombre. Registro Simultaneo de presion y Electrocardiograma Intracavetarios. Arch Inst Cardiol Mexico , 21:271.
4. Grüntzig, A., et al. (1977). Coronary transluminal angioplasty (abstract). Circulation , 56:II-319.
5.Agostoni, P. et al. (2004). Radial versus femoral apporach for percutaneous coronary diagnostic and interventional procedures-Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol , 44:349-356.